PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $415,000 | +38.3% | 7,800 | +51.5% | 0.07% | +126.7% |
| Q2 2022 | $300,000 | -97.7% | 5,150 | -96.9% | 0.03% | -97.1% |
| Q1 2022 | $12,799,000 | +26.6% | 167,712 | -0.1% | 1.02% | +38.7% |
| Q4 2021 | $10,106,000 | +91.6% | 167,950 | +123.2% | 0.73% | +0.4% |
| Q1 2021 | $5,274,000 | +1905.3% | 75,245 | +974.9% | 0.73% | +3955.6% |
| Q3 2017 | $263,000 | +10.5% | 7,000 | +40.0% | 0.02% | +28.6% |
| Q2 2017 | $238,000 | -96.4% | 5,000 | -96.6% | 0.01% | -95.8% |
| Q1 2017 | $6,612,000 | +28.7% | 145,000 | -8.8% | 0.33% | +39.8% |
| Q4 2016 | $5,136,000 | -80.4% | 159,000 | -46.2% | 0.24% | -76.4% |
| Q1 2015 | $26,237,000 | +0.6% | 295,294 | +0.4% | 1.00% | -5.9% |
| Q4 2014 | $26,089,000 | +2.0% | 294,260 | +11.6% | 1.06% | +0.1% |
| Q3 2014 | $25,566,000 | +20.9% | 263,780 | +14.6% | 1.06% | +7.3% |
| Q2 2014 | $21,151,000 | +31.8% | 230,250 | +0.4% | 0.99% | +4.8% |
| Q1 2014 | $16,051,000 | +18.7% | 229,335 | -2.5% | 0.94% | -2.9% |
| Q4 2013 | $13,523,000 | -9.9% | 235,225 | -24.7% | 0.97% | -24.9% |
| Q3 2013 | $15,010,000 | – | 312,230 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |